The CANSLIM Growth Model Portfolio is up over 51% in 2023-2025 and is 21% ahead of it s benchmark BSMAX.
The CANSLIM Growth Model Portfolio was updated this weekend. New Adds of 6 stocks were made and Removals of 5 stocks were made. All prices are as of 01/24/2025. A total of 20 stocks are in the Portfolio.
The Model Portfolio is made up of 17 to 22 stocks. The criteria used to select the stocks is using the CANSLIM approach. CANSLIM represents the seven characteristics that top-performing stocks often share before making their biggest price gains. Not all the characteristics are being used since some of them are subjective or I cannot backtest. The characteristics I am using are Earnings per share (EPS) and related data concerning EPS, Return on Equity and Sales increase.
BackTest – The Backtest for this Portfolio outperformed the IJR benchmark in 18 out of the 19 years tested. It was largely even with the benchmark in 2018. When the Portfolio outperformed, it was usually by a wide margin. The best year was 2013 when it was up by 46%
Add – AMPH, ATEN, CMCSA, NSSC, OSW, SSTK
Remove – BBW, ESEA, INMD, PAGS, WEN
Notable outperformers in the Active portfolio are NCLH up 46% since added and G up 44% since added.
See the CANSLIM Growth Portfolio Detail Here

Performance 01/01/2023 to 01/24/2025
| Quant Alpha’s * | 176.16% |
| EQAL (Russell 1000 Equal Weight ETF) * | 25.49% |
| BI-Weekly Swings | 73.70% |
| BSMAX ( Russell Small/Mid-Cap Index Fund) | 29.73% |
| Small Cap Discoveries | 70.73% |
| IJR (Small Cap benchmark) | 24.16% |
| CANSLIM Growth | 51.29% |
| BSMAX ( Russell Small/Mid-Cap Index Fund) | 29.73% |
| Mid Cap Flyers | 44.92% |
| MDY (Mid Cap Benchmark) | 31.74% |
| Large Cap Stalwarts | 50.28% |
| RSP (Large Cap benchmark) | 26.73% |
Click here for the Live scorecard
Backtests for the Model Portfolios

The CANSLIM Growth Model Portfolio continues its dramatic outperformance over its benchmark from 01/01/23 to today. The Portfolio is up over 51% since it started in 2023. The Portfolio continues to maintain its substantial outperformance over its benchmark BSMAX.
All content on this site is for informational purposes only and does not constitute financial advice. Consult relevant financial professionals in your country of residence to get personalized advice before you make any trading or investing decisions. Disclaimer
Copyright 2023-2025 SwingTrader.Trading. All Rights Reserved.


You must be logged in to post a comment.